valproic acid has been researched along with Albuminuria in 2 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To quantify absolute and relative risks of chronic kidney disease (CKD) progression and acute kidney injury (AKI) in people who initiated lithium compared with valproate therapy and to investigate the association between cumulative use and elevated lithium levels and kidney outcomes." | 4.31 | Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden. ( Bellocco, R; Bosi, A; Carrero, JJ; Ceriani, L; Chang, Z; Clase, CM; Elinder, CG; Fu, EL; Landén, M; Runesson, B; Sjölander, A, 2023) |
| " Intriguingly, this reduction of GM3 and nephrin, as well as albuminuria, were inhibited by administration of valproic acid." | 4.12 | Glycosphingolipid GM3 prevents albuminuria and podocytopathy induced by anti-nephrin antibody. ( Furukawa, JI; Hanamatsu, H; Iwasaki, N; Kawashima, N; Nagane, M; Naito, S; Nakayama, KI; Takeuchi, Y; Yamashita, T, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawashima, N | 1 |
| Naito, S | 1 |
| Hanamatsu, H | 1 |
| Nagane, M | 1 |
| Takeuchi, Y | 1 |
| Furukawa, JI | 1 |
| Iwasaki, N | 1 |
| Yamashita, T | 1 |
| Nakayama, KI | 1 |
| Bosi, A | 1 |
| Clase, CM | 1 |
| Ceriani, L | 1 |
| Sjölander, A | 1 |
| Fu, EL | 1 |
| Runesson, B | 1 |
| Chang, Z | 1 |
| Landén, M | 1 |
| Bellocco, R | 1 |
| Elinder, CG | 1 |
| Carrero, JJ | 1 |
2 other studies available for valproic acid and Albuminuria
| Article | Year |
|---|---|
Glycosphingolipid GM3 prevents albuminuria and podocytopathy induced by anti-nephrin antibody.
Topics: Albuminuria; Animals; Glycosphingolipids; Mice; Podocytes; Proteinuria; Valproic Acid | 2022 |
Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden.
Topics: Acute Kidney Injury; Adult; Albuminuria; Cohort Studies; Creatinine; Female; Humans; Kidney; Lithium | 2023 |